Tag: tumor immune microenvironment

New research identifies the enzyme CYP2S1 as a driver of immunosuppressive cell recruitment and poor chemoimmunotherapy response in esophageal squamous ...

New research reveals that the epigenetic enzyme KMT9 orchestrates immune evasion in prostate cancer by recruiting suppressive myeloid cells and ...

New research shows that myeloid-derived suppressor cells drive stem-like properties in esophageal squamous cell carcinoma through an IL-1 beta-regulated HNF1A/CXCL1 ...

A multi-omics study traces cervical carcinogenesis from normal tissue to invasive cancer and identifies galectin-9-driven immune evasion as a promising ...

A comprehensive new review reveals how neutrophils, the immune system's most abundant white blood cells, are co-opted by tumors to ...

A prospective imaging study shows that radium-223 significantly reduces PD-L1 expression and depletes immune cells in prostate cancer bone metastases, ...

A single intratumoral injection of the experimental TLR4 agonist EmT4™ transformed an immunologically quiet canine soft tissue sarcoma into an ...

In a discovery that could reshape how scientists think about cancer immunotherapy, researchers in Japan have uncovered the hidden mechanism ...

Immune checkpoint inhibitors have transformed the treatment of lung adenocarcinoma, yet they fail in nearly half of the patients who ...

A small but important subset of ovarian cancers long regarded as resistant to both chemotherapy and immunotherapy may contain an ...